2,463
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Inflammatory biomarkers in saliva and serum of patients with rheumatoid arthritis with respect to periodontal status

ORCID Icon, , , , , , , , , ORCID Icon, & show all
Pages 333-344 | Received 03 Jan 2018, Accepted 19 Apr 2018, Published online: 30 Apr 2018

References:

  • Kaufman E, Lamster IB. Analysis of saliva for periodontal diagnosis-a review.J Clin Periodontol. 2000;27:453–465.
  • Miller CS, King Jr CP, Langub MC, et al. Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc. 2006;137:322–329.
  • Ben-Aryeh H, Nahir M, Scharf Y, et al. Sialochemistry of patients with rheumatoid arthritis. electrolytes, protein, and salivary IgA. Oral Surg Oral Med Oral Pathol. 1978;45:63–70.
  • Sorsa T, Gursoy UK, Nwhator S, et al. Analysis of matrix metalloproteinases, especially MMP-8, in gingival crevicular fluid, mouthrinse and saliva for monitoring periodontal diseases. Periodontol 2000. 2016;70:142–163.
  • Fosang AJ, Last K, Neame PJ, et al. Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan. Biochem J. 1994;304:347–351.
  • Verstappen J, Von den Hoff JW. Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease. J Dent Res. 2006;85:1074–1086.
  • Sorsa T, Tjäderhane L, Konttinen YT, et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med. 2006;38:306–321.
  • Mattey DL, Nixon NB, Dawes PT. Association of circulating levels of MMP-8 with mortality from respiratory disease in patients with rheumatoid arthritis. Arthritis Res Ther. 2012;14:R204.
  • Pussinen PJ, Sarna S, Puolakkainen M, et al. The balance of serum matrix metalloproteinase-8 and its tissue inhibitor in acute coronary syndrome and its recurrence. Int J Cardiol. 2013;31:362–368.
  • Kormi I, Nieminen MT, Havulinna AS, et al. Matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 predict incident cardiovascular disease events and all-cause mortality in a population-based cohort. Eur J Prev Cardiol. 2017;24:1136–1144.
  • Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front Biosci. 2006;11:529–534.
  • Uitto VJ, Suomalainen K, Sorsa T. Salivary collagenase: origin, characteristics and relationship to periodontal health. J Periodontal Res. 1990;25:135–142.
  • Tchetverikov I, Ronday HK, Van El B, et al. MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis. Ann Rheum Dis. 2004;63:881–883.
  • Rathnayake N, Åkerman S, Klinge B, et al. Salivary biomarkers of oral health- a cross-sectional study. J Clin Periodontol. 2012;40:140–147.
  • Nishimoto N, Kishimoto T, Yoshizaki K. Anti-interleukin 6 receptor antibody treatment in rheumatic disease. Ann Rheum Dis. 2000;59:i21–i27.
  • Kishimoto T. Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther. 2006;8:S2.
  • Sack U, Kinne RW, Marx T, et al. Interleukin-6 in synovial fluid is closely associated with chronic synovitis in rheumatoid arthritis. Rheumatol Int. 1993;13:45–51.
  • Madhok R, Crilly A, Watson J, et al. Serum interleukin-6 levels in rheumatoid arthritis: correlation with clinical and laboratory indices of disease activity. Ann Rheum Dis. 1993;52:232–234.
  • Lee HJ, Kang IK, Chung CP, et al. The subgingival microflora and gingival crevicular fluid cytokines in refractory periodontitis. J Clin Periodontol. 1995;22:885–890.
  • Kobayashi T, Ishida K, Yoshie H. Increased expression of interleukin-6 (IL-6) gene transcript in relation to IL-6 promoter hypomethylation in gingival tissue from patients with chronic periodontitis. Arch Oral Biol. 2016;69:89–94.
  • Nishikawa Y, Kajiura Y, Lew JH, et al. Calprotectin induces IL-6 and MCP-1 production via toll-like receptor 4 signaling in human gingival fibroblasts. J Cell Physiol. 2017;232:1862–1871.
  • Äyräväinen L, Leirisalo-Repo M, Kuuliala A, et al. Periodontitis in early and chronic rheumatoid arthritis: a prospective follow-up study in Finnish population. BMJ Open. 2017;7:e011916.
  • Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–324.
  • Oral Health Surveys Basic Methods. 4th ed. Geneva: World Health Organization; 1997.
  • Page RC, Eke PI. Case definitions for use in population-based surveillance of periodontitis. J Periodontol. 2007;78:1387–1399.
  • Eke PI, Page RC, Wei L, et al. Update of the case definitions for population-based surveillance for periodontitis. J Periodontol. 2012;83:1449–1454.
  • Lindy O, Suomalainen K, Mäkelä M, et al. Statin use is associated with fewer periodontal lesions: a retrospective study. BMC Oral Health. 2008;8:16.
  • Navazesh M, Kumar SK. University of Southern California School of Dentistry. J Am Dent Assoc. 2008;139:35S–40S.
  • Villa A, Connell CL, Abati S. Diagnosis and management of xerostomia and hyposalivation. Ther Clin Risk Manag. 2015;11:45–51.
  • Gursoy UK, Könönen E, Pradhan-Palikhe P, et al. Salivary MMP-8, TIMP-1, and ICTP as markers of advanced periodontitis. J Clin Periodontol. 2010;37:487–493.
  • Mäntylä P, Stenman M, Kinane D, et al. Monitoring periodontal disease status in smokers and nonsmokers using a gingival crevicular fluid matrix metalloproteinase-8-spesific chair-side test. J Periodontal Res. 2006;41:503–512.
  • Leppilahti JM, Kallio MA, Tervahartiala T, Sorsa T, Mäntylä P. Gingival crevicular fluid matrix metalloproteinase-8 levels predict treatment outcome among smokers with chronic periodontitis. J Periodontol. 2014;85:250–260.
  • Nylund K, Meurman JH, Heikkinen AM, et al. Periodontal inflammatory burden and salivary matrix metalloproteinase-8 concentration among patients with chronic kidney disease at the predialysis stage. J Periodontol. 2015;86:1212–1220.
  • Hemmilä I, Dakubu S, Mukkala VM, et al. Europium as a label in time-resolved immunofluorometric assays. Anal Biochem. 1984;137:335–343.
  • Buduneli E, Mäntylä P, Emingil G, et al. Acute myocardial infarction is reflected in salivary matrix metalloproteinase-8 activation level. J Periodontol. 2011;82:716–725.
  • Tuomainen AM, Nyyssönen K, Laukkanen JA, et al. Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. Arterioscler Tromb Vasc Biol. 2007;27:2722–2728.
  • Nukarinen E, Lindström O, Kuuliala K, et al. Association of matrix metalloproteinases -7, -8 and -9 and TIMP -1 with disease severity in acute pancreatitis. A cohort study. PLoS One. 2016;25:e0161480.
  • Prevoo MLL, vant’t Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44–48.
  • van Gestel AM, Prevoo MLL, vant’t Hof MA, et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum. 1996;39:34–40.
  • Fransen J, van Riel PL. The disease activity score and the EULAR response criteria. Clin Exp Rheumatol. 2005;23:S93–S99.
  • van der Heijde DM, van Leeuwen MA, van Riel PL, et al. Biannual radiographic assessments of hands and feet in a three-year prospective follow up of patients with early rheumatoid arthritis. Arthritis Rheum. 1992;35:26–34.
  • Bode JG, Albrecht U, Häussinger D, et al. Hepatic acute phase proteins–regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling. Eur J Cell Biol. 2012;91:496–505.
  • Noack M, Miossec P. Selected cytokine pathways in rheumatoid arthritis. Semin Immunopathol. 2017;39:365–383.
  • Kremer JM, Lawrence DA, Hamilton R, et al. Long-term study of the impact of methotrexate on serum cytokines and lymphocyte subsets in patients with active rheumatoid arthritis: correlation with pharmacokinetic measures. RMD Open. 2016;2:e000287.
  • Arvidson NG, Gudbjörnsson B, Larsson A, et al. The timing of glucocorticoid administration in rheumatoid arthritis. Ann Rheum Dis. 1997;56:27–31.
  • Kobayashi T, Yokoyama T, Ito S, et al. Periodontal and serum protein profiles in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitor adalimumab. J Periodontol. 2014;85:1480–1488.
  • Araújo VMA, Melo IM, Lima V. Relationship between periodontitis and rheumatoid arthritis: review of the literature. Mediators of Inflamm. 2015;2015:259074.
  • Kirchner A, Jäger J, Krohn-Grimberghe B, et al. Active matrix metalloproteinase -8 and periodontal bacteria depending on periodontal status in patients with rheumatoid arthritis. J Periodont Res. 2017;52:745–754.
  • Costa PP, Trevisan GL, Macedo GO, et al. Salivary interleukin-6, matrix metalloproteinase-8, and osteoprotegerin in patients with periodontitis and diabetes. J Periodontol. 2010;81:384–391.
  • Ebersole JL, Schuster JL, Stevens J, et al. Patterns of salivary analytes provide diagnostic capacity for distinguishing chronic adult periodontitis from health. J Clin Immunol. 2013;33:271–279.
  • Prakasam S, Srinivasan M. Evaluation of salivary biomarker profiles following non-surgical management of chronic periodontitis. Oral Dis. 2014;20:171–177.
  • Gursoy UK, Könönen E, Uitto VJ, et al. Salivary interleukin-1beta concentration and the presence of multiple pathogens in periodontitis. J Clin Periodontol. 2009;36:922–927.
  • Ramseier CA, Kinney JS, Herr AE, et al. Identification of pathogen and host-response markers correlated with periodontal disease. J Periodontol. 2009;80:436–446.
  • Teles RP, Likhari V, Socransky SS, et al. Salivary cytokine levels in subjects with chronic periodontitis and in periodontally healthy individuals: a cross-sectional study. J Periodontal Res. 2009;44:411–417.
  • Sorsa T, Hernández M, Leppilahti J, et al. Detection of gingival crevicular fluid MMP-8 levels with different laboratory and chair-side methods. Oral Dis. 2010;16:39–45.
  • Nwhator SO, Ayanbadejo PO, Umeizudike KA, et al. Clinical correlates of a lateral-flow immunoassay oral risk indicator. J Periodontol. 2014;85:188–194.
  • Heikkinen AM, Nwhator SO, Rathnayake N, et al. Pilot study on oral health status as assessed by an active matrix metalloproteinase-8 chairside mouth rinse test in adolescents. J Periodontol. 2016;87:36–40.
  • Sorsa T, Gieselmann D, Arweiler NB, et al. A quantitative point-of-care test for periodontal and dental peri-implant diseases. Nat Rev Dis Primers. 2017;14:17061–17069.
  • Mikuls TR, Payne JB, Yu F, et al. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheum (Hoboken, NJ). 2014;66:1090–1100.
  • Berthelot JM, Le Goff B. Rheumatoid arthritis and periodontal disease. Joint Bone Spine. 2010;77:537–541.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.